M.D. Zuhal Başkan is a medical oncologist with a strong clinical and professional background. She graduated from Dokuz Ege University Faculty of Medicine in 2006 and has continued to build her practice and expertise in oncology. In 2024 she joined Acıbadem Health Group, where she provides comprehensive cancer care and collaborates with multidisciplinary teams to deliver patient-centered treatment. M.D. Başkan is an active member of several professional organizations, including the Bursa Medical Chamber, the Medical Oncology Society, the Anatolian Medical Oncology Association, the İzmir Breast Diseases Association, and the Lung Cancer Association. Her memberships reflect a commitment to continuing education, professional standards, and advancing oncology practice regionally. Known for compassionate patient care and clear communication, M.D. Başkan focuses on evidence-based treatments and supports patients through diagnosis, therapy, and follow-up. She stays current with developments in oncology to offer modern, personalized care tailored to each patient’s needs.
Education
- 2006 Dokuz Eylul University Faculty of Medicine Medical Oncology
- 2000 Izmir Training and Research Hospital Internal Medicine
- 1982 – 1988 Akdeniz University Faculty of Medicine
Experience
- 2024 Acibadem Health Group
- 2009 – 2010 Izmir Tepecik Training and Research Hospital / Medical Oncology Specialist
- 2006 – 2009 Denizli State Hospital / Medical Oncology Specialist
- 2003 – 2006 Dokuz Eylul University Faculty of Medicine Department of Medical Oncology Medical Oncology residency
- 2001 – 2003 Izmir Çamdibi Dispensary
- 2000 – 2001 Izmir Cinarli S.S.K. Dispensary
- 1996 – 2000 Bozyaka Training and Research Hospital / Internal Medicine Residency
- 1995 – 1996 Izmir Bornova Dispensary
- 1992 – 1995 Izmir Tepecik Training and Research Hospital
- 1988 – 1992 Kutahya Gediz State Hospital
Memberships
- Bursa Medical Chamber
- Medical Oncology Society
- Anatolian Medical Oncology Association
- Izmir Breast Diseases Association
- Lung Cancer Association
Publications
- Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue.
Neoplasma. 2010;57(5):465-72 Celebiler Cavusoglu A, Sevinc AI, Saydam S, Canda T, Baskan Z, Kilic Y, Sakizli M. - Predicting invasive phenotype with CDH1, CDH13, CD44 and TIMP3 gene expressions in primary breast cancer.
Cancer Sci. 2009 Dec;100(12):2341-5 Celebiler (Cavusoglu) A, Kilic Y, Saydam S, Canda T, Baskan Z, Sevinc AI, Sakizli M. - Predicting invasive phenotype with CDH1, CDH13, CD44 and TIMP3 gene expressions in primary breast cancer.
Cancer Sci. 2009 Dec;100(12):2341-5. Epub 2009 Sep 1 Celebiler (Cavusoglu) A, Kilic Y, Saydam S, Canda T, Baskan Z, Sevinc AI, Sakizli M. - False negative bone scintigraphy in a patient with primary breast cancer: a possible transient phenomenon of bisphosphonate (alendronate) treatment.
Tumori. 2005 Jan-Feb;91(1):77-80 Demirkan B, Baskan Z, Alacacioglu A, Gorken IB, Bekis R, Ada E, Osma E, Alakavuklar M. - False negative bone scintigraphy in a patient with primary breast cancer: a possible transient phenomenon of bisphosphonate (alendronate) treatment.
Tumori. 2005 Jan-Feb;91(1):77-80 Baskan Z, Alacacioglu A, Gorken IB, Bekis R, Ada E, Osma E, Alakavuklar M. - Primary non-hodgkin lymphoma of breast in a patient with rectal carcinoma and magnetic resonance spectroscopic examination.
Breast. 2005 Apr;14(2):169-74 Demirkan B, Balci P, Ozcan M.A, Baskan Z, Alacacioglu A, Tuncel S.A, Canda T, Kocdor M.A, Topcu I, Undar B, Alakavuklar M. - Glucagonoma: Case report.
Ege Tıp Dergisi 41(4):247-249,2002 Alarslan P, Yıldırım A, Özkan D, Salman T, Aykas A, Başkan Z, Sop G.
